MYD88 is also recurrently mutated in other B-cell lymphomas like primary central nervous system lymphoma (PCNSL) (Gonzalez-Aguilar et al. 2012), and MLL2 and TP53 mutations have been reported for mantle cell lymphoma (MCL) (Zhang et al. 2014). This evidence concerns the gene MYD88 and primary central nervous system lymphoma.